| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $113.8M | -12.9% |
| Cost of Revenue | $64.9M | -13.8% |
| Gross Profit | $48.9M | -11.7% |
| R&D Expense | $9.4M | +10.4% |
| SG&A Expense | $22.2M | -14.9% |
| Operating Income | -$3.7M | -209.8% |
| Pre-tax Income | -$3.2M | -193.3% |
| Income Tax | -$695K | -223.4% |
| Net Income | -$2.5M | -187.4% |
| EPS (Basic) | -$0.21 | -187.5% |
| EPS (Diluted) | -$0.21 | -187.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $14.2M | -28.3% |
| Accounts Receivable | $25.9M | -12.2% |
| Inventory | $31.6M | +17.7% |
| Current Assets | $78.6M | -0.2% |
| Total Assets | $151.3M | -0.6% |
| Current Liabilities | $35.8M | +11.9% |
| Long-term Debt | $1.4M | -82.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $7.3M | +91.4% |
| Capital Expenditures | $1.6M | +23.3% |
| Investing Cash Flow | -$1.6M | +91.9% |
| Financing Cash Flow | -$8.2M | +4.8% |
| Free Cash Flow | $5.7M | +127.6% |
| $47.7M |
| -9.2% |
| Stockholders' Equity | $103.6M | +3.8% |